Accueil | Epicentre
Latest news
Bannière
News
Euvichol-S: documenting the operational effectiveness of this new oral cholera vaccine
Published on 01.12.2025
Lire l'actualité :
Euvichol-S: documenting the operational effectiveness of this new oral cholera vaccine
Bannière
News
WHO treatment decision algorithms double pediatric TB diagnoses and treatments
Published on 18.11.2025
Lire l'actualité :
WHO treatment decision algorithms double pediatric TB diagnoses and treatments
Bannière
News
HIV in South Africa: Identifying and targeting the last strongholds of the epidemic with a view to reversing it
Published on 10.10.2025
Lire l'actualité :
HIV in South Africa: Identifying and targeting the last strongholds of the epidemic with a view to reversing it
Latest publications
Low-dose yellow fever vaccination in infants: a randomised, double-blind, non-inferiority trial.
The Lancet. 2026 Feb. doi: 10.1016/S0140-6736(25)02069-0. Epub 2026 01 13
Published on
Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study.
The Lancet. Global health 2026 Feb ; 14(2); . doi: 10.1016/S2214-109X(25)00450-4. Epub 2026 01 10
Published on
Trends in Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine and amodiaquine over ten years of seasonal malaria chemoprevention in Moissala Health District, Chad.
Malaria journal 2025 Dec 31; . doi: 10.1186/s12936-025-05771-2. Epub 2025 12 31
Published on
Discover our training courses
Transmitting and transferring epidemiological knowledge is an integral part of Epicentre's mission. Training courses are provided throughout the year to MSF staff and beyond.